Squarepoint Ops LLC Achilles Therapeutics PLC Transaction History
Squarepoint Ops LLC
- $57 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding ACHL
# of Institutions
34Shares Held
23.5MCall Options Held
0Put Options Held
0-
Syncona Portfolio LTD Guernsey, Channel Islands, X011.1MShares$9.2 Million9.24% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.39MShares$1.98 Million0.42% of portfolio
-
Redmile Group, LLC San Francisco, CA1.61MShares$1.33 Million0.08% of portfolio
-
Vestal Point Capital, LP New York, NY1.5MShares$1.25 Million0.16% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.44MShares$1.2 Million0.24% of portfolio
About Achilles Therapeutics plc
- Ticker ACHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,774,000
- Market Cap $33.8M
- Description
- Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...